Philips Medical Systems and Theseus Imaging, a subsidiary of North American Scientific, have agreed to collaborate on research aimed at improving methodology for the noninvasive imaging of cardiac cell
Philips Medical Systems and Theseus Imaging, a subsidiary of North American Scientific, have agreed to collaborate on research aimed at improving methodology for the noninvasive imaging of cardiac cell death.
The two companies hope to optimize techniques and instrumentation for using Apomate, an investigational in vivo nuclear medicine imaging agent that targets cells undergoing apoptosis or necrosis. Theseus will provide images and other data from its cardiac imaging trials of Apomate to Philips. Apomate images will be fused with images taken using thallium. The collaboration may result in methods that enhance Apomate imaging, leading to increased clinical acceptance and improved clinical outcomes when Apomate imaging is applied.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.